Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapyYoshio Nakamura, Naoya Yamazaki, Shigehisa Kitano et al.|Oncotarget|2016Cited by 160
Diagnosis and Management of Basal Cell CarcinomaKeiji Tanese|Current Treatment Options in Oncology|2019Cited by 153
G-Protein-Coupled Receptor GPR49 is Up-regulated in Basal Cell Carcinoma and Promotes Cell Proliferation and Tumor FormationKeiji Tanese, Michiie Sakamoto, Mariko Fukuma et al.|American Journal Of Pathology|2008Cited by 141
Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γKeiji Tanese, Elizabeth A. Grimm, Yuuri Hashimoto et al.|Journal of Investigative Dermatology|2015Cited by 95
Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype–genotype correlation in Japanese patients with pachydermoperiostosisTakashi Sasaki, Jun Kudoh, Hironori Niizeki et al.|Journal of Dermatological Science|2012Cited by 83